Creative Financial Designs Inc Theratechnologies Inc. Transaction History

Creative Financial Designs Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$0.72 - $1.12 $1,980 - $3,080	2,750 Added 2.89%	98,019 $79,000
Q3 2022 Nov 01, 2022	BUY	$1.98 - $2.42 $100,255 - $122,534	50,634 Added 113.44%	95,269 $226,000
Q2 2022 Aug 01, 2022	BUY	$2.21 - $2.7 $98,643 - $120,514	44,635 New	44,635 $101,000
Q1 2022 Apr 15, 2022	SELL	$2.37 - $3.24 $340,597 - $465,626	-143,712 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$2.92 - $3.76 $52,849 - $68,052	18,099 Added 14.41%	143,712 $435,000

Q3 2021 Oct 08, 2021	BUY	$3.28 - $4.07 $53,365 - $66,218	16,270 Added 14.88%	125,613 $471,000
Q2 2021 Jul 27, 2021	BUY	$3.43 - $3.96 $34,591 - $39,936	10,085 Added 10.16%	109,343 $424,000
Q1 2021 Apr 19, 2021	BUY	$2.2 - $3.94 $218,367 - $391,076	99,258 New	99,258 $384,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $135M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.